Literature DB >> 24655576

APOε4 is associated with enhanced in vivo innate immune responses in human subjects.

Stephen C Gale1, Li Gao2, Carmen Mikacenic3, Susette M Coyle1, Nicholas Rafaels2, Tanda Murray Dudenkov2, Jennifer H Madenspacher4, David W Draper4, William Ge4, Jim J Aloor4, Kathleen M Azzam4, Lihua Lai4, Perry J Blackshear5, Steven E Calvano1, Kathleen C Barnes2, Stephen F Lowry1, Siobhan Corbett1, Mark M Wurfel3, Michael B Fessler6.   

Abstract

BACKGROUND: The genetic determinants of the human innate immune response are poorly understood. Apolipoprotein (Apo) E, a lipid-trafficking protein that affects inflammation, has well-described wild-type (ε3) and disease-associated (ε2 and ε4) alleles, but its connection to human innate immunity is undefined.
OBJECTIVE: We sought to define the relationship of APOε4 to the human innate immune response.
METHODS: We evaluated APOε4 in several functional models of the human innate immune response, including intravenous LPS challenge in human subjects, and assessed APOε4 association to organ injury in patients with severe sepsis, a disease driven by dysregulated innate immunity.
RESULTS: Whole blood from healthy APOε3/APOε4 volunteers induced higher cytokine levels on ex vivo stimulation with Toll-like receptor (TLR) 2, TLR4, or TLR5 ligands than blood from APOε3/APOε3 patients, whereas TLR7/8 responses were similar. This was associated with increased lipid rafts in APOε3/APOε4 monocytes. By contrast, APOε3/APOε3 and APOε3/APOε4 serum neutralized LPS equivalently and supported similar LPS responses in Apoe-deficient macrophages, arguing against a differential role for secretory APOE4 protein. After intravenous LPS, APOε3/APOε4 patients had higher hyperthermia and plasma TNF-α levels and earlier plasma IL-6 than APOε3/APOε3 patients. APOE4-targeted replacement mice displayed enhanced hypothermia, plasma cytokines, and hepatic injury and altered splenic lymphocyte apoptosis after systemic LPS compared with APOE3 counterparts. In a cohort of 828 patients with severe sepsis, APOε4 was associated with increased coagulation system failure among European American patients.
CONCLUSIONS: APOε4 is a determinant of the human innate immune response to multiple TLR ligands and associates with altered patterns of organ injury in human sepsis. Published by Mosby, Inc.

Entities:  

Keywords:  Apolipoprotein; LPS; Toll-like receptor

Mesh:

Substances:

Year:  2014        PMID: 24655576      PMCID: PMC4125509          DOI: 10.1016/j.jaci.2014.01.032

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  46 in total

1.  Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae.

Authors:  N de Bont; M G Netea; P N Demacker; B J Kullberg; J W van der Meer; A F Stalenhoef
Journal:  Eur J Clin Invest       Date:  2000-09       Impact factor: 4.686

2.  Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.

Authors:  Yuqing Huo; Andreas Schober; S Bradley Forlow; David F Smith; Matthew Craig Hyman; Steffen Jung; Dan R Littman; Christian Weber; Klaus Ley
Journal:  Nat Med       Date:  2002-12-16       Impact factor: 53.440

3.  APACHE II: a severity of disease classification system.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Crit Care Med       Date:  1985-10       Impact factor: 7.598

4.  Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes.

Authors:  T Kawai; O Takeuchi; T Fujita; J Inoue; P F Mühlradt; S Sato; K Hoshino; S Akira
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

5.  Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis.

Authors:  M Van Oosten; P C Rensen; E S Van Amersfoort; M Van Eck; A M Van Dam; J J Breve; T Vogel; A Panet; T J Van Berkel; J Kuiper
Journal:  J Biol Chem       Date:  2001-01-02       Impact factor: 5.157

Review 6.  Apolipoprotein E: far more than a lipid transport protein.

Authors:  R W Mahley; S C Rall
Journal:  Annu Rev Genomics Hum Genet       Date:  2000       Impact factor: 8.929

7.  Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins.

Authors:  Osamu Takeuchi; Shintaro Sato; Takao Horiuchi; Katsuaki Hoshino; Kiyoshi Takeda; Zhongyun Dong; Robert L Modlin; Shizuo Akira
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

8.  Differences in the association between apolipoprotein E genotype and mortality across populations.

Authors:  Douglas C Ewbank
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-08       Impact factor: 6.053

Review 9.  Endotoxaemia: an early predictor of septicaemia in febrile patients.

Authors:  S J van Deventer; H R Buller; J W ten Cate; A Sturk; W Pauw
Journal:  Lancet       Date:  1988-03-19       Impact factor: 79.321

10.  Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms.

Authors:  L M Dong; C Wilson; M R Wardell; T Simmons; R W Mahley; K H Weisgraber; D A Agard
Journal:  J Biol Chem       Date:  1994-09-02       Impact factor: 5.157

View more
  67 in total

1.  Vitamin D deficiency might pose a greater risk for ApoEɛ4 non-carrier Alzheimer's disease patients.

Authors:  Erdinç Dursun; Merve Alaylıoğlu; Başar Bilgiç; Haşmet Hanağası; Ebba Lohmann; Irem L Atasoy; Esin Candaş; Ömür Selin Araz; Burak Önal; Hakan Gürvit; Selma Yılmazer; Duygu Gezen-Ak
Journal:  Neurol Sci       Date:  2016-06-29       Impact factor: 3.307

2.  Roles of the Mevalonate Pathway and Cholesterol Trafficking in Pulmonary Host Defense.

Authors:  Kristin A Gabor; Michael B Fessler
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

Review 3.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.

Authors:  Justin M Long; David M Holtzman
Journal:  Cell       Date:  2019-09-26       Impact factor: 41.582

Review 4.  Peripheral versus central nervous system APOE in Alzheimer's disease: Interplay across the blood-brain barrier.

Authors:  Dustin Chernick; Stephanie Ortiz-Valle; Angela Jeong; Wenhui Qu; Ling Li
Journal:  Neurosci Lett       Date:  2019-06-07       Impact factor: 3.046

Review 5.  A New Frontier in Immunometabolism. Cholesterol in Lung Health and Disease.

Authors:  Michael B Fessler
Journal:  Ann Am Thorac Soc       Date:  2017-11

Review 6.  A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward.

Authors:  Michaël E Belloy; Valerio Napolioni; Michael D Greicius
Journal:  Neuron       Date:  2019-03-06       Impact factor: 17.173

7.  Dysregulation of TLR5 and TAM Ligands in the Alzheimer's Brain as Contributors to Disease Progression.

Authors:  Marisol Herrera-Rivero; Francesco Santarelli; Frederic Brosseron; Markus P Kummer; Michael T Heneka
Journal:  Mol Neurobiol       Date:  2019-03-09       Impact factor: 5.590

8.  Leucine-rich repeats and calponin homology containing 4 (Lrch4) regulates the innate immune response.

Authors:  Jim J Aloor; Kathleen M Azzam; John J Guardiola; Kymberly M Gowdy; Jennifer H Madenspacher; Kristin A Gabor; Geoffrey A Mueller; Wan-Chi Lin; Julie M Lowe; Artiom Gruzdev; Michael W Henderson; David W Draper; B Alex Merrick; Michael B Fessler
Journal:  J Biol Chem       Date:  2018-12-06       Impact factor: 5.157

Review 9.  Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight.

Authors:  Yang Shi; David M Holtzman
Journal:  Nat Rev Immunol       Date:  2018-12       Impact factor: 53.106

Review 10.  Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors.

Authors:  Mariana F Uchoa; V Alexandra Moser; Christian J Pike
Journal:  Front Neuroendocrinol       Date:  2016-09-17       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.